[1]
|
M. E. O’Dwyer, M. J. Mauro and B. J. Druker, “Recent Advancements in the Treatment of Chronic Myelogenous Leukemia,” Annual Review of Medicine, Vol. 53, 2002, pp. 369-381.
http://dx.doi.org/10.1146/annurev.med.53.082901.103853
|
[2]
|
G. S. Lordelo, A. L. Miranda-Vilela, A. K. Akimoto, et al., “Association between Methylene Tetrahydrofolate Reductase and Glutathione S-Transferase M1 Gene Polymorphisms and Chronic Myeloid Leukemia in a Brazilian Population,” Genetics and Molecular Research, Vol. 11, No. 2, 2012, pp. 1013-1026.
http://dx.doi.org/10.4238/2012.April.19.6
|
[3]
|
A. Hishida, S. Terakura, N. Emi, et al., “GSTT1 and GSTM1 Deletions, NQO1 C609T Polymorphism and Risk of Chronic Myelogenous Leukemia in Japanese,” Asian Pacific Journal of Cancer Prevention, Vol. 6, No. 3, 2005, pp. 251-255.
|
[4]
|
M. Taspinar, S. E. Aydos, O. Comez, et al., “CYP1A1, GST Gene Polymorphisms and Risk of Chronic Myeloid Leukemia,” Swiss Medical Weekly, Vol. 138, No. 1-2, 2008, pp. 12-17.
|
[5]
|
C. J. Omiecinski, J. P. Vanden Heuvel, G. H. Perdew, et al., “Xenobiotic Metabolism, Disposition, and Regulation by Receptors: From Biochemical Phenomenon to Predictors of Major Toxicities,” Toxicological Sciences, Vol. 120, No. S1, 2011, pp. S49-S75.
http://dx.doi.org/10.1093/toxsci/kfq338
|
[6]
|
G. Bhat, A. Bhat, A. Wani, et al., “Polymorphic Variation in Glutathione-S-Transferase Genes and Risk of Chronic Myeloid Leukaemia in the Kashmiri Population,” Asian Pacific Journal of Cancer Prevention, Vol. 13, No. 1, 2012, pp. 69-73.
http://dx.doi.org/10.7314/APJCP.2012.13.1.069
|
[7]
|
B. Mannervik, “The Isozymes of Glutathione S-Transferase,” Advances in Enzymology, Vol. 57, 1985, pp. 357-417.
|
[8]
|
R. C. Strange, M. A. Spiteri, S. Ramachandran, et al., “Glutathione-S-Transferase Family of Enzymes,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 482, No. 1-2, 2001, pp. 21-26.
http://dx.doi.org/10.1016/S0027-5107(01)00206-8
|
[9]
|
H. Autrup, “Genetic Polymorphisms in Human Xenobiotica Metabolizimg Enzymes as Susceptibility Factors in Toxic Response,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 464, No. 1, 2000, pp. 65-76.
http://dx.doi.org/10.1016/S1383-5718(99)00167-9
|
[10]
|
S. Landi, “Mammalian Class Theta GST and Differential Susceptibility to Carcinogens: A Review,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 463, No. 3, 2000, pp. 247-283.
http://dx.doi.org/10.1016/S1383-5742(00)00050-8
|
[11]
|
S. Tsuchida and K. Sato, “Glutathione Transferases and Cancer,” Critical Reviews in Biochemistry and Molecular Biology, Vol. 27, No. 4-5, 1992, pp. 337-384.
http://dx.doi.org/10.3109/10409239209 082566
|
[12]
|
N. R. Dunna, S. Vuree, S. Kagita, et al., “Association of GSTP1 Gene (I105V) Polymorphism with Acute Leukaemia,” Journal of Genetics, Vol. 91, 2012, pp. e60-e63.
|
[13]
|
World Medical Association, “Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects,” The 59th WMA General Assembly, Seoul, 2008.
|
[14]
|
F. Millot, A. Baruchel, J. Guilhot, et al., “Imatinib Is Effective in Children with Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial,” Journal of Clinical Oncology, Vol. 29, No. 20, 2011, pp. 2827-2832.
http://dx.doi.org/10. 1200/JCO.2010.32.7114
|
[15]
|
S. Saussele, M. Lauseker, A. Gratwohl, et al., “Allogeneic Hematopoietic Stem Cell Transplantation (Allo SCT) for Chronic Myeloid Leukemia in the Imatinib Era: Evaluation of Its Impact within a Subgroup of the Randomized German CML Study IV,” Blood, Vol. 115, No. 10, 2010, pp. 1880-1885.
http://dx.doi.org/10.1182/blood-2009-08-237115
|
[16]
|
J. R. Andolina, S. M. Neudorf and S. J. Corey, “How I Treat Childhood CML,” Blood, Vol. 119, No. 8, 2012, pp. 1821-1830. http://dx.doi.org/10.1182/blood-2011-10-380774
|
[17]
|
K. Sailaja, D. Surekha, D. N. Rao, et al., “Association of the GSTP1 Gene (Ile105Val) Polymorphism with Chronic Myeloid Leukemia,” Asian Pacific Journal of Cancer Prevention, Vol. 11, No. 2, 2010, pp. 461-464.
|
[18]
|
T. Ishii, T. Matsuse, S. Teramoto, et al., “Glutathione S-Transferase P1 (GSTP1) Polymorphism in Patients with Chronic Obstructive Pulmonary Disease,” Thorax, Vol. 54, No. 8, 1999, pp. 693-696.
http://dx.doi.org/10.1136/thx.54.8.693
|
[19]
|
B. Dawson and R. G. Trapp, “Basic and Clinical Biostatistics,” 3rd Edition, McGraw-Hill Inc., 2001.
|
[20]
|
B. Kiran, M. Karkucak, H. Ozan, et al., “GST (GSTM1, GSTT1 and GSTP1) Polymorphisms in the Genetic Susceptibility of Turkish Patients to Cervical Cancer,” Journal of Gynecologic Oncology, Vol. 21, No. 3, 2010, pp. 169-173. http://dx.doi.org/10.3802/jgo.2010.21.3.169
|
[21]
|
Z. Ye and H. Song, “Glutathione s-Transferase Polymorphisms (GSTM1, GSTP1 and GSTT1) and the Risk of Acute Leukaemia: A Systematic Review and Meta-Analysis,” European Journal of Cancer, Vol. 41, No. 7, 2005, pp. 980-989. http://dx.doi.org/10.1016/j.ejca.2005.01.014
|
[22]
|
M. Karkucak, T. Yakut, T. Gulten, et al., “Investigation of GSTP1 (Ile105Val) Gene Polymorphism in Chronic Myeloid Leukaemia Patients,” International Journal of Human Genetics, Vol. 12, No. 3, 2012, pp. 145-149.
|
[23]
|
L. W. Harries, M. J. Stubbins, D. Forman, et al., “Identification of Gentic Polymorphisms at the Glutathione S-Tranferase Pilocus and Association with Susceptibility to Bladder, Testicular and Prostate Cancer,” Carcinogenesis, Vol. 18, No. 4, 1997, pp. 641-644.
http://dx.doi.org/10.1093/ carcin/18.4.641
|
[24]
|
D. Ryberg, V. Skaug, A. Hewer, et al., “Genotypes of Glutathione Transferase M1 and P1 and Their Significance for Lung DNA Adduct Levels and Cancer Risk,” Carcinogenesis, Vol. 18, No. 7, 1997, pp. 1285-1289.
http://dx.doi.org/10.1093/carcin/18.7.1285
|
[25]
|
K. J. Helzlsouer, O. Selmin, H. Y. Huang, et al., “Association between Glutathione S-Transferase M1, P1, and T1 Genetic Polymorphisms and Development of Breast Cancer,” Journal of the National Cancer Institute (Bethesda), Vol. 90, No. 7, 1998, pp. 512-518.
http://dx.doi.org/10.1093/jnci/ 90.7.512
|
[26]
|
V. Maggini, G. Buda, S. Galimberti, et al., “Lack of Association of NQO1 and GSTP1 Polymorphisms with Multiple Myeloma Risk,” Leukemia Research, Vol. 32, No. 6, 2008, pp. 988-990.
http://dx.doi.org/10.1016/j.leukres.2007.10.008
|
[27]
|
J. D. Hayes and D. J. Pulford, “The Glutathione S-Transferase Supergene Family: Regulation of GST and the Contributions of the Isoenzymes to Cancer Chemoprotection and Drug Resistance,” Critical Reviews in Biochemistry and Molecular Biology, Vol. 30, No. 6, 1995, pp. 445-600.
http://dx.doi.org/ 10.3109/10409239509083491
|